Your browser doesn't support javascript.
loading
Urinary biomarkers for renal tract malformations.
Magalhães, Pedro; Schanstra, Joost P; Carrick, Emma; Mischak, Harald; Zürbig, Petra.
Afiliación
  • Magalhães P; a Mosaiques Diagnostics GmbH , Hannover , Germany.
  • Schanstra JP; b Department of Pediatric Nephrology, Hannover Medical School , Hannover , Germany.
  • Carrick E; c Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institute of Cardiovascular and Metabolic Disease , Toulouse , France.
  • Mischak H; d Université Toulouse III Paul-Sabatier , Toulouse , France.
  • Zürbig P; e BHF Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow , Glasgow , UK.
Expert Rev Proteomics ; 13(12): 1121-1129, 2016 12.
Article en En | MEDLINE | ID: mdl-27791437
INTRODUCTION: Renal tract malformations (RTMs) are congenital anomalies of the kidneys and urinary tract, which are the major cause of end-stage renal disease in children. Using immunoassay-based approaches (ELISA, western blot), individual urinary proteins including transforming growth factor ß, tumor necrosis factor and monocyte attractant proteins 1 were found to be associated to RTMs. However, only mass spectrometry (MS) based methods leading to the identification of panels of protein-based markers composed of fragments of the extracellular matrix allowed the prediction of progression of RTMs and its complications. Areas covered: In this review, we summarized relevant studies identified in "Pubmed" using the keywords "urinary biomarkers" and "proteomics" and "renal tract malformations" or "hydronephrosis" or "ureteropelvic junction obstruction" or "posterior urethral valves" or "vesicoureteral reflux". These publications represent studies on potential protein-based biomarkers, either individually or combined in panels, of RTMs in human and animal models. Expert commentary: Successful use in the clinic of these protein-based biomarkers will need to involve larger scale studies to reach sufficient power. Improved performance will potentially come from combining immunoassay- and MS-based markers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anomalías Urogenitales / Biomarcadores / Proteínas / Proteómica / Riñón Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Animals / Child / Humans / Male Idioma: En Revista: Expert Rev Proteomics Asunto de la revista: BIOQUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anomalías Urogenitales / Biomarcadores / Proteínas / Proteómica / Riñón Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Animals / Child / Humans / Male Idioma: En Revista: Expert Rev Proteomics Asunto de la revista: BIOQUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido